Detalhe da pesquisa
1.
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.
Blood
; 143(21): 2152-2165, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38437725
2.
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas.
Blood
; 138(5): 370-381, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33786580
3.
Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells.
Nature
; 534(7607): 341-6, 2016 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27281222
4.
CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression.
Blood
; 129(2): 199-208, 2017 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27793879
5.
Precision medicine and lymphoma.
Curr Opin Hematol
; 25(4): 329-334, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29738334
6.
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma.
Haematologica
; 105(6): 318-321, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273479
7.
Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant.
Haematologica
; 104(4): e174-e177, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29976740
8.
CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia.
Front Oncol
; 13: 1150149, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205201
9.
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.
Blood Adv
; 7(5): 845-855, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947123
10.
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma.
Blood Adv
; 6(3): 1025-1037, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34941996
11.
Applications and analysis of targeted genomic sequencing in cancer studies.
Comput Struct Biotechnol J
; 17: 1348-1359, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762958
12.
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment.
Leukemia
; 38(2): 398-402, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212534
13.
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma.
Leukemia
; 33(6): 1540, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30903015
14.
Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations.
Epigenetics
; 12(5): 370-377, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28106467
15.
Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine.
Expert Rev Mol Diagn
; 16(10): 1093-1102, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27648481
16.
Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition.
Cancer Discov
; 6(11): 1248-1257, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27630125
17.
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma.
Leukemia
; 32(5): 1261-1265, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29568095